How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 1.21-1.664 | 6,024 |
| Non-cancer disease | 1.1331-1.5 | 209 |
| Unspecified | 1.1280-1.871 | 21 |
| Metastatic cancer | 1.1261-1.488 | 339 |
| Healthy/control | 1.1251-1.447 | 465 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Head and neck | 1.6621.356-2.22 | 92 |
| Heart | 1.3791.081-2 | 1 |
| Adrenal gland | 1.3661.086-2.113 | 17 |
| Musculoskeletal | 1.3461.189-1.679 | 1 |
| Lung | 1.331-1.81 | 2,783 |
| Kidney | 1.331.056-1.709 | 25 |
| Lymphoid tissue | 1.2911.109-1.702 | 142 |
| Pancreas | 1.2751.013-1.667 | 86 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Primary cancer x Breast | 1.170-1.937 | 1 |
| Healthy/control x Liver | 10-1.628 | 2 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Primary cancer | Mean propensity | 1.297 | 6,024 | 38 |
| Non-cancer disease | Mean propensity | 1.189 | 209 | 10 |
| Unspecified | Mean propensity | 1.452 | 21 | 2 |
| Metastatic cancer | Mean propensity | 1.207 | 339 | 5 |
| Healthy/control | Mean propensity | 1.148 | 465 | 18 |
